Evidence map›Paper›PMID 39274369›Full record

ArticleJournal of clinical medicine2024

Efficacy of Desvenlafaxine in Reducing Migraine Frequency and Severity: A Retrospective Study.

Marina Stoupa Hadidi, Murad Rasheed, Yanal M Bisharat, Heba H Al Helou, Hussam A El Aina, Hala M Batayneh, Alaa A A Aljabali, Omar Gammoh

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marina Stoupa HadidiJordan Hospital, Adib Wehbeh St., Amman 11152, Jordan.
Murad RasheedThe Specialty Hospital, Hunayn Bin Ishak St, Amman 11193, Jordan.
Yanal M BisharatMedical Affairs Department, MS Pharma Regional Office, Zahran Plaza Bldg., 7th Circle Amman, Amman 11844, Jordan.
Heba H Al HelouMedical Affairs Department, MS Pharma Regional Office, Zahran Plaza Bldg., 7th Circle Amman, Amman 11844, Jordan.
Hussam A El AinaMarketing Department, MS Pharma Regional Office, Zahran Plaza Bldg., 7th Circle Amman, Amman 11844, Jordan.
Hala M BataynehMarketing Department, MS Pharma Regional Office, Zahran Plaza Bldg., 7th Circle Amman, Amman 11844, Jordan.
Alaa A A AljabaliDepartment of Pharmaceutics and Pharmaceutical Technology, Yarmouk University, Irbid 21163, Jordan.ORCID 0000-0002-9519-6338
Omar GammohDepartment of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Yarmouk University, Irbid 21163, Jordan.ORCID 0000-0001-8801-2652

Funding

CSRD VA 1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

desvenlafaxinedisabilityepisodesfrequencyheadachemigrainepainprophylaxisseveritywomen

Identifiers

PMID39274369
PMCPMC11396083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.